PBI
49
3
CVX
40
3
R
65
2
AMAT
48
-2
NWL
36
5
PPL
80
-5
EL
28
-2
MUR
31
4
NSC
50
-4
CINF
51
3
CLX
55
-4
SWKS
44
-9
DTE
42
-3
BWA
50
2
MMM
59
-2
VRSK
70
-3
KSS
26
5
MU
60
4
HRB
65
5
FRT
53
2
PBI
49
3
CVX
40
3
R
65
2
AMAT
48
-2
NWL
36
5
PPL
80
-5
EL
28
-2
MUR
31
4
NSC
50
-4
CINF
51
3
CLX
55
-4
SWKS
44
-9
DTE
42
-3
BWA
50
2
MMM
59
-2
VRSK
70
-3
KSS
26
5
MU
60
4
HRB
65
5
FRT
53
2
Financhill
Back

Gilead Sciences 10K Form

Buy
55

GILD
Gilead Sciences

Last Price:
$103.66
Seasonality Move:
6.99%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-08 10Q GILD/Gilead Sciences Quarterly
2024-02-23 10K GILD/Gilead Sciences Annual
2023-11-07 10Q GILD/Gilead Sciences Quarterly
2023-08-04 10Q GILD/Gilead Sciences Quarterly
2023-05-03 10Q GILD/Gilead Sciences Quarterly
2023-02-22 10K GILD/Gilead Sciences Annual

Receive GILD News And Ratings

See the #1 stock for the next 7 days that we like better than GILD

GILD Financial Statistics

Sales & Book Value

Annual Sales: $28.8B
Cash Flow: $1.8B
Price / Cash Flow: 12.56
Annual Sales: $15.32
Price / Book: 6.74

Profitability

EPS (TTM): 4.75000
Net Income (TTM): $6B
Gross Margin: $22.5B
Return on Equity: 32.29%
Return on Assets: 10.66%

Gilead Sciences Earnings Forecast

Key Gilead Sciences Financial Ratios

  • The Gross Profit Margin over the past 34 years for GILD is 78.26%.
  • The Selling, General & Administrative Expenses for GILD have been equal to 21.18% of Gross Profit Margin.
  • The Research & Development expenses have been 20.54% of Revenue.
  • The Interest Expense is 203.54% of Operating Income.
  • The Net Earning history of GILD is 1.67% of Total Revenues.
  • Per Share Earnings over the last 34 years have been positive in 21 years.

Gilead Sciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Biotechnology
Sector: Health Care
Current Symbol: GILD
CUSIP: 375558
Website: gilead.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1.3
Quick Ratio: 1

Price-to-Earnings

Trailing P/E Ratio: 271.71
Forward P/E Ratio: 12.2

GILD Technical Analysis vs Fundamental Analysis

Buy
55
Gilead Sciences (GILD) is a Buy

Is Gilead Sciences a Buy or a Sell?

  • Gilead Sciences stock is rated a Buy
    The current Gilead Sciences [GILD] share price is $103.25. The Score for GILD is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.